68ga-bnota-prgd2
Small moleculeexperimentalImaging agent
Clinical trial activity
6 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
6
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Dec 1, 2011 (NCT01527058)
Timeline
2010s
- Jan 1, 2011
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Unspecified targetRadiopharmaceutical
radiopharmaceutical
Chemistry & pharmacology
- Imaging
- 68-gallium
Oral
No
Parenteral
No
Topical
No
Also known as
- 68ga-bnota-prgd2
- 68ga-bnota-prgd2
- 68gallium-bnota-prgd2
- 68ga-nota-prgd2
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02511197 | Early Phase 1 (Phase 1) | May 1, 2015 | Tsinghua University |
| NCT01801371 | Early Phase 1 (Phase 1) | Oct 1, 2012 | Capital Medical University, Tsinghua University |
| NCT01542073 | Early Phase 1 (Phase 1) | Feb 1, 2012 | Tsinghua University |
| NCT01656785 | Early Phase 1 (Phase 1) | Feb 1, 2012 | Tsinghua University |
| NCT01940926 | Early Phase 1 (Phase 1) | Feb 1, 2012 | Tsinghua University |
| NCT01527058 | Early Phase 1 (Phase 1) | Dec 1, 2011 | Tsinghua University |
Showing 6 of 6 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Tsinghua University | Academic/Hospital | 6 | 6 | 1 | 2011 |
| Capital Medical University | Academic/Hospital | 1 | 0 | 1 | 2012 |
2 organizations
Page 1 / 1